European Society of Thoracic Surgeons electronic quality of life application after lung resection: field testing in a clinical setting.
ApplicationPatient Reported Outcome Measures
Lung cancer
Quality of life
Video-assisted thoracoscopic surgery
Journal
Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399
Informations de publication
Date de publication:
27 05 2021
27 05 2021
Historique:
received:
18
09
2020
revised:
30
11
2020
accepted:
12
12
2020
pubmed:
29
4
2021
medline:
15
10
2021
entrez:
28
4
2021
Statut:
ppublish
Résumé
Technology has the potential to assist healthcare professionals in improving patient-doctor communication during the surgical journey. Our aims were to assess the acceptability of a quality of life (QoL) application (App) in a cohort of cancer patients undergoing lung resections and to depict the early perioperative trajectory of QoL. This multicentre (Italy, UK, Spain, Canada and Switzerland) prospective longitudinal study with repeated measures used 12 lung surgery-related validated questions from the European Organisation for Research and Treatment of Cancer Item Bank. Patients filled out the questionnaire preoperatively and 1, 7, 14, 21 and 28 days after surgery using an App preinstalled in a tablet. A one-way repeated measures analysis of variance was run to determine if there were differences in QoL over time. A total of 103 patients consented to participate in the study (83 who had lobectomies, 17 who had segmentectomies and 3 who had pneumonectomies). Eighty-three operations were performed by video-assisted thoracoscopic surgery (VATS). Compliance rates were 88%, 90%, 88%, 82%, 71% and 56% at each time point, respectively. The results showed that the operation elicited statistically significant worsening in the following symptoms: shortness of breath (SOB) rest (P = 0.018), SOB walk (P < 0.001), SOB stairs (P = 0.015), worry (P = 0.003), wound sensitivity (P < 0.001), use of arm and shoulder (P < 0.001), pain in the chest (P < 0.001), decrease in physical capability (P < 0.001) and scar interference on daily activity (P < 0.001) during the first postoperative month. SOB worsened immediately after the operation and remained low at the different time points. Worry improved following surgery. Surgical access and forced expiratory volume in 1 s (FEV1) are the factors that most strongly affected the evolution of the symptoms in the perioperative period. We observed good early compliance of patients operated on for lung cancer with the European Society of Thoracic Surgeons QoL App. We determined the evolution of surgery-related QoL in the immediate postoperative period. Monitoring these symptoms remotely may reduce hospital appointments and help to establish early patient-support programmes.
Identifiants
pubmed: 33909903
pii: 6257241
doi: 10.1093/icvts/ivab030
pmc: PMC8691569
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
911-920Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Références
J Am Med Inform Assoc. 2009 Jul-Aug;16(4):550-60
pubmed: 19390112
BMC Cancer. 2018 Jul 3;18(1):707
pubmed: 29970033
Acta Oncol. 2015 May;54(5):600-8
pubmed: 25751758
Am J Manag Care. 2008 Aug;14(8):530-9
pubmed: 18690769
BMC Surg. 2019 Sep 2;19(1):125
pubmed: 31477107
J Med Internet Res. 2005 Mar 31;7(1):e11
pubmed: 15829473
Int J Med Inform. 2014 Apr;83(4):235-48
pubmed: 24529817
Ann Oncol. 2017 Oct 1;28(10):2332-2333
pubmed: 28961852
J Thorac Dis. 2018 Dec;10(12):7055-7063
pubmed: 30746252
Health Qual Life Outcomes. 2010 Mar 30;8:35
pubmed: 20353582
Lung Cancer. 2019 May;131:47-57
pubmed: 31027697
Eur J Cancer. 2019 Nov;121:55-63
pubmed: 31561134
Ann Thorac Surg. 2017 Jul;104(1):245-253
pubmed: 28483154
Lancet Oncol. 2016 Jun;17(6):836-844
pubmed: 27160473
Eur Heart J. 2016 May 07;37(18):1428-38
pubmed: 26873093
Ann Oncol. 2017 Sep 1;28(9):2305-2311
pubmed: 28911065
Eur J Cardiothorac Surg. 2010 Mar;37(3):525-30
pubmed: 19850491
Interact Cardiovasc Thorac Surg. 2015 Oct;21(4):415-9
pubmed: 26105771
Lancet Oncol. 2020 May;21(5):723-732
pubmed: 32213338
Ann Thorac Surg. 2009 Apr;87(4):1007-12; discussion 1012-3
pubmed: 19324120
J Comput Mediat Commun. 2010 Apr;15(3):367-388
pubmed: 21760702
Int J Med Inform. 2013 Jul;82(7):593-603
pubmed: 23507561
J Thorac Cardiovasc Surg. 2008 Sep;136(3):597-604
pubmed: 18805257
J Clin Oncol. 2004 Feb 15;22(4):714-24
pubmed: 14966096
J Med Internet Res. 2016 Jan 08;18(1):e6
pubmed: 26747176
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):91-115
pubmed: 30304509
J Cancer Educ. 2017 Mar;32(1):91-96
pubmed: 26511536